What are the major opportunities in the Live Attenuated Vaccines market? What are the strategies for the Live Attenuated Vaccines market?

For detailed insights on the major opportunities and strategies in the Live Attenuated Vaccines market, Read More

How does the Live Attenuated Vaccines market relate to the overall economy and other similar markets?

For detailed insights on Live Attenuated Vaccines's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Live Attenuated Vaccines market growth? SWOT analysis of the Live Attenuated Vaccines market.

For detailed insights on the key dynamics influencing the Live Attenuated Vaccines market growth and SWOT analysis of the Live Attenuated Vaccines industry, Read More

Live Attenuated Vaccines Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Live Attenuated Vaccines Market Report 2026

Name: Live Attenuated Vaccines Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Vaccine Type (Monovalent, Multivalent), By Route Of Administration (Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated), By Indication (Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Live Attenuated Vaccines Market Overview

• Live Attenuated Vaccines market size has reached to $25.95 billion in 2025

• Expected to grow to $41.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%

• Growth Driver: The Increasing Prevalence Of Infectious Diseases Is Fueling The Growth Of The Market Due To Rising Global Incidence And Demand For Effective Long-Term Immunization

• Market Trend: Advancements In Single-Dose Live Attenuated Vaccines For Enhanced Immunization

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Live Attenuated Vaccines Market?

Live attenuated vaccines are biological formulations that use a weakened version of a virus or bacterium, engineered in the lab to prevent it from causing illness in healthy individuals. By closely simulating a natural infection, these vaccines trigger a robust and long-lasting immune response, often requiring only one or two doses for effective protection against infectious diseases.

The main types of live attenuated vaccines include monovalent and multivalent. Monovalent refers to a substance, such as a vaccine or ion, that is effective against or involves only one specific antigen, strain, or type. It is administered through various routes of administration, such as intramuscular, subcutaneous, oral attenuated, and intranasal attenuated, for several indications, including influenza, measles, mumps, and rubella (MMR), polio, chickenpox, shingles, rotavirus, and others. It is distributed through various distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and is used by various end-users, including hospitals, clinics, diagnostic centers, research institutes, and others.

Live Attenuated Vaccines Market Global Report 2026 Market Report bar graph

What Is The Live Attenuated Vaccines Market Size and Share 2026?

The live attenuated vaccines market size has grown strongly in recent years. It will grow from $25.95 billion in 2025 to $28.52 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to global infectious disease burden, government immunization initiatives, childhood vaccination policies, hospital-based vaccine delivery, WHO vaccination programs.

What Is The Live Attenuated Vaccines Market Growth Forecast?

The live attenuated vaccines market size is expected to see strong growth in the next few years. It will grow to $41.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to booster vaccination demand, emerging infectious disease risks, cold chain infrastructure expansion, global health funding, next-generation vaccine platforms. Major trends in the forecast period include expansion of national immunization programs, growing demand for pediatric vaccination, advances in vaccine stability and storage, increased focus on pandemic preparedness, multivalent vaccine development.

Book your 30 minutes free consultation with our research experts

Global Live Attenuated Vaccines Market Segmentation

1) By Vaccine Type: Monovalent, Multivalent

2) By Route Of Administration: Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated

3) By Indication: Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users

Subsegments:

1) By Monovalent: Single-Dose Vaccines, Multiple-Dose Vaccines

2) By Multivalent: Bivalent Vaccines, Trivalent Vaccines, Quadrivalent Vaccines, Other Multivalent Vaccines

What Is The Driver Of The Live Attenuated Vaccines Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the live attenuated vaccines market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person, animal, or environment to another. Rising global travel accelerates the spread of infectious diseases by allowing pathogens to cross borders faster than containment efforts. Live attenuated vaccines help prevent infectious diseases by stimulating a strong immune response with weakened pathogens, ensuring long-term immunity and reducing disease spread. For instance, in March 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2023, an estimated 10.8 million people fell ill with TB worldwide, including 6.0 million men, 3.6 million women, and 1.3 million children. Therefore, the increasing prevalence of infectious diseases is driving the growth of the live attenuated vaccines industry.

Key Players In The Global Live Attenuated Vaccines Market

Major companies operating in the live attenuated vaccines market are Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, CSL Limited, GC Biopharma, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Valneva SE, Southern Research, BioFarma, Bharat Biotech International Limited, Meissa Vaccines Inc., BioDiem Ltd., Bio-Med Limited, Naobios, Lakshmi Pharmaceuticals

Global Live Attenuated Vaccines Market Trends and Insights

Major companies operating in the live attenuated vaccines market are focusing on developing advanced products such as single-dose vaccines to enhance immunization efficiency and improve patient compliance. Single-dose vaccines provide lasting immunity with a single shot, eliminating the need for multiple doses. This simplifies vaccination for patients and healthcare providers, enhancing convenience and accessibility. For instance, in November 2023, Valneva SE, a France-based biotech company that manufactures vaccines for infectious diseases, announced the launch of IXCHIQ, which received approval from the U.S. Food and Drug Administration (FDA), a US-based health agency. It is the world’s first live-attenuated chikungunya vaccine indicated for adults aged 18 and older. This approval is significant because IXCHIQ is the world's first licensed vaccine for chikungunya, addressing an unmet medical need for protection against this mosquito-borne viral disease, which can cause severe fever, joint and muscle pain, and other symptoms

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Live Attenuated Vaccines Market?

In May 2023, Bavarian Nordic A/S, a Denmark-based biotechnology company, acquired a travel health business from Emergent BioSolutions Inc. for approximately $380 million. With this acquisition, Bavarian Nordic aims to expand its vaccine portfolio, including VIVOTIF for typhoid fever, VAXCHORA for cholera, and the chikungunya vaccine candidate CHIKV VLP, along with its manufacturing and development facilities in Switzerland and California. Emergent BioSolutions Inc. is a US-based biopharmaceutical company that manufactures live attenuated vaccines.

Regional Insights

North America was the largest region in the live attenuated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Live Attenuated Vaccines Market?

The live attenuated vaccine market consists of sales of viral live attenuated vaccines, bacterial live attenuated vaccines, and intranasal live attenuated vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Live Attenuated Vaccines Market Report 2026?

The live attenuated vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the live attenuated vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Live Attenuated Vaccines Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$28.52 billion
Revenue Forecast In 2035	$41.11 billion
Growth Rate	CAGR of 9.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Vaccine Type, Route Of Administration, Indication, Distribution Channel, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, CSL Limited, GC Biopharma, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Valnev
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Live Attenuated Vaccines Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Live Attenuated Vaccines Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Live Attenuated Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Live Attenuated Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Expansion Of National Immunization Programs

4.2.2 Growing Demand For Pediatric Vaccination

4.2.3 Advances In Vaccine Stability And Storage

4.2.4 Increased Focus On Pandemic Preparedness

4.2.5 Multivalent Vaccine Development

5. Live Attenuated Vaccines Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Public Health Centers

5.4 Immunization Centers

5.5 Research Institutes

6. Live Attenuated Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Live Attenuated Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Live Attenuated Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Live Attenuated Vaccines Market Size, Comparisons And Growth Rate Analysis

7.3. Global Live Attenuated Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Live Attenuated Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Live Attenuated Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Live Attenuated Vaccines Market Segmentation

9.1. Global Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monovalent, Multivalent

9.2. Global Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated

9.3. Global Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications

9.4. Global Live Attenuated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.5. Global Live Attenuated Vaccines Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users

9.6. Global Live Attenuated Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single-Dose Vaccines, Multiple-Dose Vaccines

9.7. Global Live Attenuated Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bivalent Vaccines, Trivalent Vaccines, Quadrivalent Vaccines, Other Multivalent Vaccines

10. Live Attenuated Vaccines Market Regional And Country Analysis

10.1. Global Live Attenuated Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Live Attenuated Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Live Attenuated Vaccines Market

11.1. Asia-Pacific Live Attenuated Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Live Attenuated Vaccines Market

12.1. China Live Attenuated Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Live Attenuated Vaccines Market

13.1. India Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Live Attenuated Vaccines Market

14.1. Japan Live Attenuated Vaccines Market Overview

14.2. Japan Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Live Attenuated Vaccines Market

15.1. Australia Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Live Attenuated Vaccines Market

16.1. Indonesia Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Live Attenuated Vaccines Market

17.1. South Korea Live Attenuated Vaccines Market Overview

17.2. South Korea Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Live Attenuated Vaccines Market

18.1. Taiwan Live Attenuated Vaccines Market Overview

18.2. Taiwan Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Live Attenuated Vaccines Market

19.1. South East Asia Live Attenuated Vaccines Market Overview

19.2. South East Asia Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Live Attenuated Vaccines Market

20.1. Western Europe Live Attenuated Vaccines Market Overview

20.2. Western Europe Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Live Attenuated Vaccines Market

21.1. UK Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Live Attenuated Vaccines Market

22.1. Germany Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Live Attenuated Vaccines Market

23.1. France Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Live Attenuated Vaccines Market

24.1. Italy Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Live Attenuated Vaccines Market

25.1. Spain Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Live Attenuated Vaccines Market

26.1. Eastern Europe Live Attenuated Vaccines Market Overview

26.2. Eastern Europe Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Live Attenuated Vaccines Market

27.1. Russia Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Live Attenuated Vaccines Market

28.1. North America Live Attenuated Vaccines Market Overview

28.2. North America Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Live Attenuated Vaccines Market

29.1. USA Live Attenuated Vaccines Market Overview

29.2. USA Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Live Attenuated Vaccines Market

30.1. Canada Live Attenuated Vaccines Market Overview

30.2. Canada Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Live Attenuated Vaccines Market

31.1. South America Live Attenuated Vaccines Market Overview

31.2. South America Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Live Attenuated Vaccines Market

32.1. Brazil Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Live Attenuated Vaccines Market

33.1. Middle East Live Attenuated Vaccines Market Overview

33.2. Middle East Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Live Attenuated Vaccines Market

34.1. Africa Live Attenuated Vaccines Market Overview

34.2. Africa Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Segmentation By Route Of Administration, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Live Attenuated Vaccines Market Regulatory and Investment Landscape

36. Live Attenuated Vaccines Market Competitive Landscape And Company Profiles

36.1. Live Attenuated Vaccines Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Live Attenuated Vaccines Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Live Attenuated Vaccines Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

37. Live Attenuated Vaccines Market Other Major And Innovative Companies

Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, CSL Limited, GC Biopharma, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Valneva SE, Southern Research, BioFarma, Bharat Biotech International Limited, Meissa Vaccines Inc., BioDiem Ltd., Bio-Med Limited, Naobios, Lakshmi Pharmaceuticals

38. Global Live Attenuated Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Live Attenuated Vaccines Market

40. Live Attenuated Vaccines Market High Potential Countries, Segments and Strategies

40.1 Live Attenuated Vaccines Market In 2030 - Countries Offering Most New Opportunities

40.2 Live Attenuated Vaccines Market In 2030 - Segments Offering Most New Opportunities

40.3 Live Attenuated Vaccines Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Live Attenuated Vaccines Market, Overview Of Key Products - Product Examples

Table 2: Global Live Attenuated Vaccines Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Live Attenuated Vaccines Market, Supply Chain Analysis

Table 4: Global Live Attenuated Vaccines Market, Major Raw Material Providers

Table 5: Global Live Attenuated Vaccines Market, Major Resource Providers

Table 6: Global Live Attenuated Vaccines Market, Major Manufacturers (Suppliers)

Table 7: Global Live Attenuated Vaccines Market, Major Distributors And Channel Partners

Table 8: Global Live Attenuated Vaccines Market, Key Technologies & Future Trends

Table 9: Global Live Attenuated Vaccines Market, Major Trends

Table 10: Global Live Attenuated Vaccines Market, Major End Users

Table 11: Global Live Attenuated Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Live Attenuated Vaccines Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Live Attenuated Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Live Attenuated Vaccines Market - TAM, US$ Billion, 2025

Table 15: Global Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Live Attenuated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Live Attenuated Vaccines Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Live Attenuated Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Live Attenuated Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Live Attenuated Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Live Attenuated Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Live Attenuated Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Live Attenuated Vaccines Market - Company Scoring Matrix

Table 98: Merck & Co. Inc. Financial Performance

Table 99: Sanofi SA Financial Performance

Table 100: AstraZeneca plc Financial Performance

Table 101: Abbott Laboratories Financial Performance

Table 102: GlaxoSmithKline plc Financial Performance

Table 103: Global Live Attenuated Vaccines Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Live Attenuated Vaccines Market, Competitive Dashboard

Table 105: Global Live Attenuated Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Live Attenuated Vaccines Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Table 107: Global, Live Attenuated Vaccines Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 108: Global, Live Attenuated Vaccines Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

Figure 1: Global Live Attenuated Vaccines Market, Overview Of Key Products - Product Examples

Figure 2: Global Live Attenuated Vaccines Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Live Attenuated Vaccines Market, Supply Chain Analysis

Figure 4: Global Live Attenuated Vaccines Market, Major Raw Material Providers

Figure 5: Global Live Attenuated Vaccines Market, Major Resource Providers

Figure 6: Global Live Attenuated Vaccines Market, Major Manufacturers (Suppliers)

Figure 7: Global Live Attenuated Vaccines Market, Major Distributors And Channel Partners

Figure 8: Global Live Attenuated Vaccines Market, Key Technologies & Future Trends

Figure 9: Global Live Attenuated Vaccines Market, Major Trends

Figure 10: Global Live Attenuated Vaccines Market, Major End Users

Figure 11: Global Live Attenuated Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Live Attenuated Vaccines Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Live Attenuated Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Live Attenuated Vaccines Market - TAM, US$ Billion, 2025

Figure 15: Global Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Live Attenuated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Live Attenuated Vaccines Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Live Attenuated Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Live Attenuated Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Live Attenuated Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Live Attenuated Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Live Attenuated Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Live Attenuated Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Live Attenuated Vaccines Market - Company Scoring Matrix

Figure 98: Merck & Co. Inc. Financial Performance

Figure 99: Sanofi SA Financial Performance

Figure 100: AstraZeneca plc Financial Performance

Figure 101: Abbott Laboratories Financial Performance

Figure 102: GlaxoSmithKline plc Financial Performance

Figure 103: Global Live Attenuated Vaccines Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Live Attenuated Vaccines Market, Competitive Dashboard

Figure 105: Global Live Attenuated Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Live Attenuated Vaccines Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Figure 107: Global, Live Attenuated Vaccines Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 108: Global, Live Attenuated Vaccines Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Vaccine Contract Manufacturing Market Report 2026 - Global Outlook – By Service Type (Fill-Finish, Bulk Product), By Vaccine Type (Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit ...

Travel Vaccines Market Report 2026 - Global Outlook – By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By ...

Vaccine Adjuvants Market Report 2026 - Global Outlook – By Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types), By Route of Application (Human Vaccine...

Conjugate Vaccine Market Report 2026 - Global Outlook – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meni...

Vaccine Delivery Devices Market Report 2026 - Global Outlook – By Type Of Device (Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors), By R...

Inactivated Vaccines Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inacti...

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Frequently Asked Questions

How big is the Live Attenuated Vaccines Market?

The Live Attenuated Vaccines market was valued at $25.95 billion in 2025, increased to $28.52 billion in 2026, and is projected to reach $41.11 billion by 2030.

What is the Live Attenuated Vaccines market growth?

The global Live Attenuated Vaccines market is expected to grow at a CAGR of 9.6% from 2026 to 2035 to reach $41.11 billion by 2035.

Who are the key players in Live Attenuated Vaccines market?

Some Key Players in the Live Attenuated Vaccines market Include, Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, CSL Limited, GC Biopharma, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Valneva SE, Southern Research, BioFarma, Bharat Biotech International Limited, Meissa Vaccines Inc., BioDiem Ltd., Bio-Med Limited, Naobios, Lakshmi Pharmaceuticals .

What is the anticipated growth trend for the Live Attenuated Vaccines market?

Major trend in this market includes: Advancements In Single-Dose Live Attenuated Vaccines For Enhanced Immunization. For further insights on this market. request a sample here

Which region has the most growth potential in the Live Attenuated Vaccines market?

North America was the largest region in the live attenuated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.